Pn Cardiovascular Rel6 July09
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Pn Cardiovascular Rel6 July09 as PDF for free.
More details
- Words: 1,726
- Pages: 7
Release 6
Discover the New Release 6 in Cardiovascular Ultrasound Genoa, Italy (July 10, 2009) - Esaote, a global leader in Cardiology Ultrasound, invites you to discover the ultimate features of the MyLab™GOLD Platform systems and the New Release - vers 6 - for Cardiac/Vascular Applications.
iQProbes Technology - New Cardiovascular Transducers PA240, Wideband Phased Array Probe RF
QAS* - Quality Arterial Stiffness
XStrainTM Advanced Technology Improvements AHS, Aided Heart Segmentation RCA, Regional Curves Analysis Extensions High Definition Zoom Duplex-Triplex Improvements Framingham Risk Score Calculator in CV Disease DICOM Structured Report for Vascular Export DICOM of Stress Echo Protocol
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
iQProbes Technology – New Cardiovascular Transducers Discover the innovative iQProbes Technology in Cardiovascular Imaging: it represents the next generation of transducers suitable for a wide range of clinical applications. Thanks to its extraordinary, innovative, gold standard quality design, the new iQ Transducers bring into the market a breakthrough in the manufacturing process of Ultrasound probes. The combination of the Active Matrix Composite Material,
Microscopic view of the Active Matrix Composite Material
Multiple Adaptive Layers, the Structure Filling Material and the Low-Absorption Geometric Lens Manufacturing Process delivers huge improvements in terms of Signal to Noise ratio providing unmatched sensitivity. It maximizes the transmission efficiency to provide superb B-Mode spatial/contrast resolution and Gold Standard Colour and Spectral Doppler in both near and far field applications.
Microscopic view of the Multiple Adaptive Layers Technology
PA240, Wideband Phased Array Probe Discover the new PA240 Phased Array Probe designed for impressive echocardiography and transcranial examinations in adult patient. Thanks to its brand new ergonomic, light design and anatomical probe head profile, the new PA240 iQProbe offers extraordinary comfort during the examination for both patient and operator. Even difficult-to-scan patients won’t feel any discomfort usually caused by the intense probe pressure on the ribs. Soft probe corners and tip edges are the best solution for patient’s comfort, while easy handling shape and cable-to-probe connection soft body represents the best ergonomics for end user activities.
The PA240 can provide multi-frequency operative working modalities in all available modes (B, Tissue Enhancement Imaging, XView, Colour Doppler, Tissue Velocity, Spectral PW-CW Doppler and Contrast Tuned Imaging). Based on its exceptional design and state of the art performance, the PA240 can meet every expectation in penetration capability (depth range up to 36 cm), Image Quality resolution, and Colour & Spectral Doppler sensitivity.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
RF
QAS* - Quality Arterial Stiffness
Discover the RF-based Quality Arterial Stiffness, the most accurate assessment of arterial vessel health condition. Based on the same RF-based and Real Time technology, RFQAS provides additional several parameters which combined with the available standard ultrasound acquisition offer to the physician an extraordinary tool to evaluate the arterial
stiffness condition. Starting from the analysis of the blood vessel wall properties, the algorithm is looking at vessel diameter and its relevant distension and stiffness. The procedure is based under the guidance of the Standard Deviation (SD) value, to guarantee an high value in measure feedback reliability.
The extraordinary importance of RFQAS technology is based on the accurate resolution of the measure (far superior to currently available alternative options). Thanks to the RF analysis, the system can offer increased user independence and greater accuracy of the measurements compared to all other available solutions. The LA523, LA522 and LA332 are available to perform the RFQAS modality. In vitro set-up - Eindhoven University of Technology (TU/e)
RFQAS
(Quality Arterial Stiffness) together with RFQIMT (Quality Intima Media Thickness) are part of the exclusive Esaote Advanced Vascular Package.
Due to Real-Time Analysis of the RF signal, the Advanced Vascular Package represents a precise and reliable tool for vascular diagnosis.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
XStrainTM Advanced Technology Improvements AHS, Aided Heart Segmentation Discover the AHS, the Esaote’s exclusive tool to assist physicians during XStrainTM analysis. The relevant aim is to provide a software driven, easy to use and “operator independent” procedure to obtain a very accurate tracking points positioning. The latter is applicable with dedicated methods for both apical and short axis views to standardize diagnostic results. The procedure is based on anatomical heart landmarks identification without the need for template matching algorithms.
The tool takes into consideration the Standard Heart Segmentation (ASE Segmentation), and has been designed to rely on a different number of points according to the heart view under exam. The AHS is an extraordinary help in reducing inter-intra operator variability, diagnosis follow-up and to make the point insertion procedure easier, faster and more accurate.
XStrainTM Advanced Technology Improvements RCA, Regional Curves Analysis Extensions
Example of Longitudinal Displacement (mm) in Apical 4CH View
The RCA, Regional Curves Analysis, function was extended to cover all the parameters provided by the XStrainTM technology. Relying on the ASE heart segmentation, the RCA simplifies the data interpretation providing one single averaged graph for each heart segment. It represents the best and quickest way to score heart segments functionality. It allows an overall assessment of all cardiac parameters by using a smart and immediate graphycal representation. The physicians can anyway perform further measurements based on time, peaks, shifts and delays.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
High Definition Zoom Discover the new High definition zoom now available in real-time as alternative to the conventional zoom. The choice between high resolution zoom and conventional zoom can be performed according to the user preferences. High definition zoom only acquires the image inside the ROI (Region Of Interest). As a result, spatial resolution, contrast resolution, frame rate are maximized so that even the smallest structures can be clearly visualised and analysed.
Example of HD Zoom - Heart
Duplex-Triplex Improvements Discover the new Triplex (B+CFM+PW) and Duplex (B+PW) modes with the highest velocity range never reached. Thanks to the advanced algorithm, unexpected velocity ranges can be achieved even in Triplex mode, allowing a more reliable assessment and measurement of the color doppler signal, more comfortably and in less time. Triplex and Duplex modalities are available in Vascular and Cardiac applications. Example of Triplex modality
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
Framingham Risk Score Calculator in CV Disease Discover the Framingham Risk Score Calculator in Cardiovacular Disease (CVD), available on all systems. The Framingham Risk Score was developed from the Framingham Heart Study of the Cardiovascular risk – under the direction of the National Heart Institute (now National Heart, Lung, and Blood Institute or NHLBI), and indicates the individual risk of developing CVD over a 10-year-risk. The objective was to identify the common factors or characteristics that contribute to CVD by following its development. CVD is the leading cause of death and serious illness in the USA. The Study started in 1948, and was completed in 2005: it followed a large group of patients (30-74 years old) over a
long period of time in order to determine which kind of risk factors could predict the CVD development. The predictors were fixed in: age, sex, total cholesterol, HDL cholesterol, LDL cholesterol categories, diabetes, smoking status, systolic blood pressure categories. Thanks to the innovative tutorial the user can perform the Framingham Risk Score Calculator operations in an easy and fast way by filling the dedicated fields in with the required predictors parameters and following the suggested procedure step by step. A final report with the Risk Score is also available.
Example of Framingham Risk Score Calculation in CV Disease
DICOM Structured Report for Vascular Discover the DICOM Structured Report for Vascular specifically designed for encoding and exchanging information by using the DICOM hierarchical structure and services.
This innovative document architecture introduces a new concept for structuring and encoding medical reports in a standardized manner.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
Export DICOM of Stress Echo Protocol Discover the DICOM Export of the Stress Echo Protocol: the user can easily send any patient examination containing a correctly tagged Stress Echo Protocol to any PACS.
Example of DICOM Export of Stress Echo Protocol
* RFQAS is not available for sales in the US market.
Esaote is a leading European manufacturer of medical diagnostic equipment, the worldwide leader in dedicated MRI and one of the main players in information technology. Information about Esaote and its products is available on the Internet: www.esaote.com
© 2009 - Esaote S.p.A. All rights are reserved. Technology and features of the Release 6 are system/configuration dependent. Specifications subject to change without notice. For further details, please contact your Esaote sales representative: [email protected]
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
Discover the New Release 6 in Cardiovascular Ultrasound Genoa, Italy (July 10, 2009) - Esaote, a global leader in Cardiology Ultrasound, invites you to discover the ultimate features of the MyLab™GOLD Platform systems and the New Release - vers 6 - for Cardiac/Vascular Applications.
iQProbes Technology - New Cardiovascular Transducers PA240, Wideband Phased Array Probe RF
QAS* - Quality Arterial Stiffness
XStrainTM Advanced Technology Improvements AHS, Aided Heart Segmentation RCA, Regional Curves Analysis Extensions High Definition Zoom Duplex-Triplex Improvements Framingham Risk Score Calculator in CV Disease DICOM Structured Report for Vascular Export DICOM of Stress Echo Protocol
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
iQProbes Technology – New Cardiovascular Transducers Discover the innovative iQProbes Technology in Cardiovascular Imaging: it represents the next generation of transducers suitable for a wide range of clinical applications. Thanks to its extraordinary, innovative, gold standard quality design, the new iQ Transducers bring into the market a breakthrough in the manufacturing process of Ultrasound probes. The combination of the Active Matrix Composite Material,
Microscopic view of the Active Matrix Composite Material
Multiple Adaptive Layers, the Structure Filling Material and the Low-Absorption Geometric Lens Manufacturing Process delivers huge improvements in terms of Signal to Noise ratio providing unmatched sensitivity. It maximizes the transmission efficiency to provide superb B-Mode spatial/contrast resolution and Gold Standard Colour and Spectral Doppler in both near and far field applications.
Microscopic view of the Multiple Adaptive Layers Technology
PA240, Wideband Phased Array Probe Discover the new PA240 Phased Array Probe designed for impressive echocardiography and transcranial examinations in adult patient. Thanks to its brand new ergonomic, light design and anatomical probe head profile, the new PA240 iQProbe offers extraordinary comfort during the examination for both patient and operator. Even difficult-to-scan patients won’t feel any discomfort usually caused by the intense probe pressure on the ribs. Soft probe corners and tip edges are the best solution for patient’s comfort, while easy handling shape and cable-to-probe connection soft body represents the best ergonomics for end user activities.
The PA240 can provide multi-frequency operative working modalities in all available modes (B, Tissue Enhancement Imaging, XView, Colour Doppler, Tissue Velocity, Spectral PW-CW Doppler and Contrast Tuned Imaging). Based on its exceptional design and state of the art performance, the PA240 can meet every expectation in penetration capability (depth range up to 36 cm), Image Quality resolution, and Colour & Spectral Doppler sensitivity.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
RF
QAS* - Quality Arterial Stiffness
Discover the RF-based Quality Arterial Stiffness, the most accurate assessment of arterial vessel health condition. Based on the same RF-based and Real Time technology, RFQAS provides additional several parameters which combined with the available standard ultrasound acquisition offer to the physician an extraordinary tool to evaluate the arterial
stiffness condition. Starting from the analysis of the blood vessel wall properties, the algorithm is looking at vessel diameter and its relevant distension and stiffness. The procedure is based under the guidance of the Standard Deviation (SD) value, to guarantee an high value in measure feedback reliability.
The extraordinary importance of RFQAS technology is based on the accurate resolution of the measure (far superior to currently available alternative options). Thanks to the RF analysis, the system can offer increased user independence and greater accuracy of the measurements compared to all other available solutions. The LA523, LA522 and LA332 are available to perform the RFQAS modality. In vitro set-up - Eindhoven University of Technology (TU/e)
RFQAS
(Quality Arterial Stiffness) together with RFQIMT (Quality Intima Media Thickness) are part of the exclusive Esaote Advanced Vascular Package.
Due to Real-Time Analysis of the RF signal, the Advanced Vascular Package represents a precise and reliable tool for vascular diagnosis.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
XStrainTM Advanced Technology Improvements AHS, Aided Heart Segmentation Discover the AHS, the Esaote’s exclusive tool to assist physicians during XStrainTM analysis. The relevant aim is to provide a software driven, easy to use and “operator independent” procedure to obtain a very accurate tracking points positioning. The latter is applicable with dedicated methods for both apical and short axis views to standardize diagnostic results. The procedure is based on anatomical heart landmarks identification without the need for template matching algorithms.
The tool takes into consideration the Standard Heart Segmentation (ASE Segmentation), and has been designed to rely on a different number of points according to the heart view under exam. The AHS is an extraordinary help in reducing inter-intra operator variability, diagnosis follow-up and to make the point insertion procedure easier, faster and more accurate.
XStrainTM Advanced Technology Improvements RCA, Regional Curves Analysis Extensions
Example of Longitudinal Displacement (mm) in Apical 4CH View
The RCA, Regional Curves Analysis, function was extended to cover all the parameters provided by the XStrainTM technology. Relying on the ASE heart segmentation, the RCA simplifies the data interpretation providing one single averaged graph for each heart segment. It represents the best and quickest way to score heart segments functionality. It allows an overall assessment of all cardiac parameters by using a smart and immediate graphycal representation. The physicians can anyway perform further measurements based on time, peaks, shifts and delays.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
High Definition Zoom Discover the new High definition zoom now available in real-time as alternative to the conventional zoom. The choice between high resolution zoom and conventional zoom can be performed according to the user preferences. High definition zoom only acquires the image inside the ROI (Region Of Interest). As a result, spatial resolution, contrast resolution, frame rate are maximized so that even the smallest structures can be clearly visualised and analysed.
Example of HD Zoom - Heart
Duplex-Triplex Improvements Discover the new Triplex (B+CFM+PW) and Duplex (B+PW) modes with the highest velocity range never reached. Thanks to the advanced algorithm, unexpected velocity ranges can be achieved even in Triplex mode, allowing a more reliable assessment and measurement of the color doppler signal, more comfortably and in less time. Triplex and Duplex modalities are available in Vascular and Cardiac applications. Example of Triplex modality
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
Framingham Risk Score Calculator in CV Disease Discover the Framingham Risk Score Calculator in Cardiovacular Disease (CVD), available on all systems. The Framingham Risk Score was developed from the Framingham Heart Study of the Cardiovascular risk – under the direction of the National Heart Institute (now National Heart, Lung, and Blood Institute or NHLBI), and indicates the individual risk of developing CVD over a 10-year-risk. The objective was to identify the common factors or characteristics that contribute to CVD by following its development. CVD is the leading cause of death and serious illness in the USA. The Study started in 1948, and was completed in 2005: it followed a large group of patients (30-74 years old) over a
long period of time in order to determine which kind of risk factors could predict the CVD development. The predictors were fixed in: age, sex, total cholesterol, HDL cholesterol, LDL cholesterol categories, diabetes, smoking status, systolic blood pressure categories. Thanks to the innovative tutorial the user can perform the Framingham Risk Score Calculator operations in an easy and fast way by filling the dedicated fields in with the required predictors parameters and following the suggested procedure step by step. A final report with the Risk Score is also available.
Example of Framingham Risk Score Calculation in CV Disease
DICOM Structured Report for Vascular Discover the DICOM Structured Report for Vascular specifically designed for encoding and exchanging information by using the DICOM hierarchical structure and services.
This innovative document architecture introduces a new concept for structuring and encoding medical reports in a standardized manner.
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
Export DICOM of Stress Echo Protocol Discover the DICOM Export of the Stress Echo Protocol: the user can easily send any patient examination containing a correctly tagged Stress Echo Protocol to any PACS.
Example of DICOM Export of Stress Echo Protocol
* RFQAS is not available for sales in the US market.
Esaote is a leading European manufacturer of medical diagnostic equipment, the worldwide leader in dedicated MRI and one of the main players in information technology. Information about Esaote and its products is available on the Internet: www.esaote.com
© 2009 - Esaote S.p.A. All rights are reserved. Technology and features of the Release 6 are system/configuration dependent. Specifications subject to change without notice. For further details, please contact your Esaote sales representative: [email protected]
Esaote S.p.A. International Activities: Via di Caciolle 15 - 50127 Firenze, ITALY - Tel +39 055 4229 1, Fax +39 055 4229 208 – e-mail: [email protected] Domestic Activities: Via A. Siffredi, 58 - 16153 Genova, ITALY - Tel +39 010 6547 1, Fax +30 010 6547 275 – e-mail: [email protected] Website: www.esaote.com
Related Documents
Pn Cardiovascular Rel6 July09
June 2020 1
Pn Cardiovascular March09
June 2020 5
Pn
August 2019 41
Pn
July 2020 17
Pn
June 2020 16